Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
暂无分享,去创建一个
D. Hayes | S. Whelan | D. Goldfarb | M. B. Major | T. Schrank | S. Brody | Dhaval P. Bhatt | A. Horani | Paul W. Rothlauf | Sebla B. Kutluay | Heejoon Jo | Nakyung Lee | P. W. Rothlauf | Adam Leitman Bailey | M. Agajanian | Kyle M. LaPak | Kasyap Tenneti | Maritza N. Puray-Chavez | H. Vuong | Christian Shema Mugisha | Keanu Davis | J. Elliott | Ria Jasuja | Dana Q. Lawson | Jenna E. Eschbach | Maritza Puray-Chavez
[1] Klaus H. Kaestner Lab. Single-cell RNA sequencing v1 , 2021, protocols.io.
[2] T. Peacock,et al. SARS-CoV-2 one year on: evidence for ongoing viral adaptation , 2021, The Journal of general virology.
[3] D. Fremont,et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies , 2021, Nature Medicine.
[4] D. Fremont,et al. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization , 2021, Cell Host & Microbe.
[5] Qiang Zhou,et al. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells , 2021, Cell Research.
[6] Anirudh Prabhu,et al. Reproducible Workflow , 2020, Transparent and Reproducible Social Science Research.
[7] N. Neff,et al. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses , 2020, Nature Communications.
[8] S. Neelamegham,et al. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration , 2020, eLife.
[9] A. Helenius,et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity , 2020, Science.
[10] Kara Dolinski,et al. The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions , 2020, Protein science : a publication of the Protein Society.
[11] N. McKenna,et al. Consensus transcriptional regulatory networks of coronavirus-infected human cells , 2020, Scientific data.
[12] Vineet D. Menachery,et al. Evasion of Type I Interferon by SARS-CoV-2 , 2020, Cell Reports.
[13] Benjamin P. Kellman,et al. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 , 2020, Cell.
[14] S. Chanda,et al. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells , 2020, Cell Reports.
[15] A. Boon,et al. A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture , 2020, mSphere.
[16] Y. Xiong,et al. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA , 2020, bioRxiv.
[17] Andrew Emili,et al. SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors , 2020, bioRxiv.
[18] C. Rice,et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants , 2020, bioRxiv.
[19] Lisa E. Gralinski,et al. Potently neutralizing and protective human antibodies against SARS-CoV-2 , 2020, Nature.
[20] Benjamin P. Kellman,et al. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 , 2020, bioRxiv.
[21] W. Zuo,et al. Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2 , 2020, American journal of respiratory and critical care medicine.
[22] N. Ban,et al. SARS-CoV-2 Nsp1 binds ribosomal mRNA channel to inhibit translation , 2020, bioRxiv.
[23] D. Fremont,et al. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2 , 2020, Cell Host & Microbe.
[24] Sebla B. Kutluay,et al. A facile Q-RT-PCR assay for monitoring SARS-CoV-2 growth in cell culture , 2020, bioRxiv.
[25] Florian P Bayer,et al. Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing , 2020, Molecular & Cellular Proteomics.
[26] Catherine E. Costello,et al. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 , 2020, bioRxiv.
[27] Andrew R. Leach,et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection , 2020, Cell.
[28] I. Solomon,et al. In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19 , 2020, Modern Pathology.
[29] C. Rice,et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses , 2020, bioRxiv.
[30] D. Matthews,et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection , 2020, Science.
[31] D. Fremont,et al. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2. , 2020, SSRN.
[32] Akiko Iwasaki,et al. Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19 , 2020, Cell Host & Microbe.
[33] Lisa E. Gralinski,et al. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract , 2020, Cell.
[34] D. Fremont,et al. Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2 , 2020, bioRxiv.
[35] S. Ciesek,et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets , 2020, Nature.
[36] Fang Li,et al. Cell entry mechanisms of SARS-CoV-2 , 2020, Proceedings of the National Academy of Sciences.
[37] Asif Shajahan,et al. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2 , 2020, bioRxiv.
[38] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[39] Fabian J Theis,et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes , 2020, Nature Medicine.
[40] T. Niewold. Type I interferon , 2020, Cytokine.
[41] O. Tsang,et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study , 2020, The Lancet Microbe.
[42] Timothy K. Soh,et al. Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2 , 2020, bioRxiv.
[43] V. Cagno,et al. SARS-CoV-2 cellular tropism , 2020, The Lancet Microbe.
[44] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[45] Dong Yang,et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] Shinji Makino,et al. An Infectious cDNA Clone of SARS-CoV-2 , 2020, Cell Host & Microbe.
[47] Paul J. Hanson,et al. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue , 2020, European Respiratory Journal.
[48] C. Lindskog,et al. The protein expression profile of ACE2 in human tissues , 2020, bioRxiv.
[49] Yan Liu,et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV , 2020, Nature Communications.
[50] Jie Hao,et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection , 2020, Frontiers of Medicine.
[51] Vineet D. Menachery,et al. Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV. , 2020, bioRxiv.
[52] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[53] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[54] Andrea Marzi,et al. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.
[55] Shuye Zhang,et al. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses , 2020, bioRxiv.
[56] Young-Jun Park,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[57] B. Graham,et al. Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation , 2020, bioRxiv.
[58] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[59] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[60] Mi Seon Kim,et al. Identification of Coronavirus Isolated from a Patient in Korea with COVID-19 , 2020, Osong public health and research perspectives.
[61] A. Phelan,et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease , 2020, The Lancet.
[62] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[63] S. Rothenburg,et al. Species-Specific Host-Virus Interactions: Implications for Viral Host Range and Virulence. , 2020, Trends in microbiology.
[64] A. Walls,et al. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors , 2019, Nature Structural & Molecular Biology.
[65] J. Hughes,et al. TRIM69 Inhibits Vesicular Stomatitis Indiana Virus , 2019, Journal of Virology.
[66] Alexandra C Walls,et al. Structural basis for human coronavirus attachment to sialic acid receptors , 2019, Nature Structural & Molecular Biology.
[67] B. Fielding,et al. Coronavirus envelope protein: current knowledge , 2019, Virology Journal.
[68] M. Diamond,et al. Shared and Distinct Functions of Type I and Type III Interferons. , 2019, Immunity.
[69] B. Bosch,et al. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A , 2019, Proceedings of the National Academy of Sciences.
[70] T. Willson,et al. WNT Activates the AAK1 Kinase to Promote Clathrin-Mediated Endocytosis of LRP6 and Establish a Negative Feedback Loop , 2019, Cell reports.
[71] The UniProt Consortium,et al. UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..
[72] Wendy S. Barclay,et al. Host and viral determinants of influenza A virus species specificity , 2018, Nature Reviews Microbiology.
[73] Andreas Ruepp,et al. CORUM: the comprehensive resource of mammalian protein complexes—2019 , 2018, Nucleic Acids Res..
[74] Ronald J. Moore,et al. Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry , 2018, Nature Protocols.
[75] M. Raaben,et al. Reconstruction of the cell entry pathway of an extinct virus , 2018, bioRxiv.
[76] J. Schoggins. Recent advances in antiviral interferon-stimulated gene biology , 2018, F1000Research.
[77] A. Ustione,et al. Establishment of the early cilia preassembly protein complex during motile ciliogenesis , 2018, Proceedings of the National Academy of Sciences.
[78] Andrew D. Huber,et al. Multiplex single-cell visualization of nucleic acids and protein during HIV infection , 2017, Nature Communications.
[79] M. Tortorici,et al. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein , 2017, Proceedings of the National Academy of Sciences.
[80] Y. Xiang,et al. Structure of SARS-CoV spike glycoprotein , 2017 .
[81] Geet Duggal,et al. Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference , 2017, Nature Methods.
[82] Jüergen Cox,et al. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.
[83] S. Makino,et al. Viral and Cellular mRNA Translation in Coronavirus-Infected Cells , 2016, Advances in Virus Research.
[84] E. Schmidt,et al. Heparan Sulfate in the Developing, Healthy, and Injured Lung. , 2016, American journal of respiratory cell and molecular biology.
[85] M. Robinson,et al. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences , 2015, F1000Research.
[86] M. Robinson,et al. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. , 2015, F1000Research.
[87] J. Mesirov,et al. The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .
[88] R. Baric,et al. Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme , 2015, Journal of Virology.
[89] Shibo Jiang,et al. Receptor Usage and Cell Entry of Porcine Epidemic Diarrhea Coronavirus , 2015, Journal of Virology.
[90] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[91] A. Kohara,et al. The Genome Landscape of the African Green Monkey Kidney-Derived Vero Cell Line , 2014, DNA research : an international journal for rapid publication of reports on genes and genomes.
[92] Henning Hermjakob,et al. The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..
[93] S. Brody,et al. Rho-associated protein kinase inhibition enhances airway epithelial Basal-cell proliferation and lentivirus transduction. , 2013, American journal of respiratory cell and molecular biology.
[94] Kate S. Wilson,et al. Whole-exome capture and sequencing identifies HEATR2 mutation as a cause of primary ciliary dyskinesia. , 2012, American journal of human genetics.
[95] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[96] M. Diamond,et al. Interferon-Induced Ifit2/ISG54 Protects Mice from Lethal VSV Neuropathogenesis , 2012, PLoS pathogens.
[97] M. Malim,et al. HIV Restriction Factors and Mechanisms of Evasion. , 2012, Cold Spring Harbor perspectives in medicine.
[98] G. Cheng,et al. Systematic identification of type I and type II interferon-induced antiviral factors , 2012, Proceedings of the National Academy of Sciences.
[99] Krishna Shankara Narayanan,et al. Severe Acute Respiratory Syndrome Coronavirus Protein nsp1 Is a Novel Eukaryotic Translation Inhibitor That Represses Multiple Steps of Translation Initiation , 2012, Journal of Virology.
[100] Krishna Shankara Narayanan,et al. SARS Coronavirus nsp1 Protein Induces Template-Dependent Endonucleolytic Cleavage of mRNAs: Viral mRNAs Are Resistant to nsp1-Induced RNA Cleavage , 2011, PLoS pathogens.
[101] C. D. de Haan,et al. Binding of Avian Coronavirus Spike Proteins to Host Factors Reflects Virus Tropism and Pathogenicity , 2011, Journal of Virology.
[102] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[103] Matthew D. Wilkerson,et al. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..
[104] Davis J. McCarthy,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[105] Shinji Makino,et al. A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein , 2009, Nature Structural &Molecular Biology.
[106] Ping Li,et al. The Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus Inhibits Cell Cytokinesis and Proliferation by Interacting with Translation Elongation Factor 1α , 2008, Journal of Virology.
[107] Krishna Shankara Narayanan,et al. Severe Acute Respiratory Syndrome Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected Cells , 2008, Journal of Virology.
[108] D. Liu,et al. Coronavirus Spike Protein Inhibits Host Cell Translation by Interaction with eIF3f , 2008, PloS one.
[109] P. Masters,et al. The Molecular Biology of Coronaviruses , 2006, Advances in Virus Research.
[110] P. Palese,et al. 7a Protein of Severe Acute Respiratory Syndrome Coronavirus Inhibits Cellular Protein Synthesis and Activates p38 Mitogen-Activated Protein Kinase , 2006, Journal of Virology.
[111] A. Lo,et al. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‐CoV) and its putative receptor, angiotensin‐converting enzyme 2 (ACE2) , 2004, The Journal of pathology.
[112] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[113] S. Schmid,et al. Differential requirements for AP-2 in clathrin-mediated endocytosis , 2003, The Journal of cell biology.
[114] B. Williams,et al. ISG20, a New Interferon-induced RNase Specific for Single-stranded RNA, Defines an Alternative Antiviral Pathway against RNA Genomic Viruses* , 2003, The Journal of Biological Chemistry.
[115] S. Brody,et al. Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[116] S. Schmid,et al. Identification of an adaptor-associated kinase, AAK1, as a regulator of clathrin-mediated endocytosis , 2002, The Journal of cell biology.
[117] L. Enjuanes,et al. Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity , 1996, Journal of virology.
[118] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[119] P. Staeheli,et al. Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. , 1992, Virology.
[120] O. Haller,et al. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein , 1990, Journal of virology.
[121] J. Rowley,et al. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[122] P. Palese,et al. Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[123] S. Pestka,et al. Convenient assay for interferons , 1981, Journal of virology.
[124] J. Melnick,et al. Defectiveness of Interferon Production and of Rubella Virus Interference in a Line of African Green Monkey Kidney Cells (Vero) , 1968, Journal of virology.
[125] Florey,et al. The endothelial cell. , 1966, British medical journal.
[126] Qin Ning,et al. Clinical and immunological features of severe and moderate coronavirus disease 2019 , 2020 .
[127] J. Mesirov,et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.
[128] R. Levi‐montalcini,et al. Growth and differentiation. , 1962, Annual review of physiology.
[129] P. Sarnow,et al. Infectious cDNA Clone , 2022 .